Skip to main content
Article
178 Long-term improvements in physical function of disease-modifying anti-rheumatic drug/biologic-experienced and disease-modifying anti-rheumatic drug-naïve psoriatic arthritis subjects treated with apremilast
Rheumatology (2018)
  • Philip J Mease, University of Washington
  • Alvin F Wells, University of California, San Diego
  • Jurgen Wollenhaupt, Hochschule Hannover
  • Stephen Hall, Monash University
  • Filip Van den Bosch, Ghent University Hospital
  • Eric Lespessailles, University of Orléans
  • Dianne Nguyen, Celgene
  • Lichen Teng, Celgene
  • Christopher J Edwards, University of Southampton
Publication Date
April 1, 2018
DOI
10.1093/rheumatology/key075.402
Citation Information
Philip J Mease, Alvin F Wells, Jurgen Wollenhaupt, Stephen Hall, et al.. "178 Long-term improvements in physical function of disease-modifying anti-rheumatic drug/biologic-experienced and disease-modifying anti-rheumatic drug-naïve psoriatic arthritis subjects treated with apremilast" Rheumatology Vol. 57 (2018)
Available at: http://works.bepress.com/philip-mease/7/